IPG Health CEO Dana Maiman announced that Shaheed Peera joined FCB Health Europe as Global Creative Partner. Best known as founder of the Creative Floor Awards, in addition to other countless achievements, Peera will partner with creative leaders, championing collaboration, diversity & inclusion and continued unparalleled creative excellence across the FCB Health family of agencies.
If you are not happy with the results below please do another search
50 search results for:
Two weeks after winning U.S. approval as a treatment for adults with Waldenstrom’s macroglobulinemia, BeiGene’s Brukinsa scored again as a treatment for adult patients with relapsed or refractory marginal zone lymphoma (MZL).
According to a California WARN notice, Sanofi is shuttering Principia Biopharma’s laboratories in San Francisco and laying off about three dozen employees after the Phase III PEGASUS trial failure of rilzabrutinib for pemphigus.
With gender inequality a continued area of focus for corporations and workplaces around the globe, the Healthcare Businesswomen’s Association (HBA) recognized Merck & Co. Inc. and Otsuka America Pharmaceutical Inc. for exemplary workplace initiatives working to close the gender gap in the healthcare and life science industries.
Eli Lilly said on Sept. 15 the U.S. government bought 388,000 additional doses of the company’s Covid-19 antibody therapy and Regeneron Pharmaceuticals said on Sept. 14 the U.S. government was buying 1.4 million additional doses of the Covid-19 antibody cocktail REGEN-COV., as infections surge due to the fast-spreading Delta variant.
A U.S. judge in New York on Sept. 14 temporarily blocked the state from enforcing a requirement that healthcare workers receive Covid-19 vaccines against the wishes of employees with religious objections.
Fully integrated biopharmaceutical solutions organization Syneos Health announced the acquisition of StudyKIK, a leading technology-enabled clinical trial recruitment and retention company.
A study of 614 fully vaccinated health workers in India found a “significant” drop in their Covid-fighting antibodies within four months of the first shot.
Pancreatic cancer has the lowest survival rate of the most common cancers as less than 10 percent of patients survive longer than five years, largely due to most cases being diagnosed at a late stage. A collaboration between NovoCure and Roche hopes to improve those odds.
A patient treated with Astellas Pharma’s experimental gene therapy for patients with X-linked Myotubular Myopathy (XLMTM) died after reports of a serious adverse event following treatment with AT132.